197 related articles for article (PubMed ID: 18078820)
1. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3.
Forte E; Orsatti L; Talamo F; Barbato G; De Francesco R; Tomei L
Biochim Biophys Acta; 2008 Feb; 1783(2):334-44. PubMed ID: 18078820
[TBL] [Abstract][Full Text] [Related]
2. 2-D Difference in gel electrophoresis combined with Pro-Q Diamond staining: a successful approach for the identification of kinase/phosphatase targets.
Orsatti L; Forte E; Tomei L; Caterino M; Pessi A; Talamo F
Electrophoresis; 2009 Jul; 30(14):2469-76. PubMed ID: 19639567
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783.
Tian W; Qu L; Meng L; Liu C; Wu J; Shou C
BMC Biochem; 2012 Oct; 13():22. PubMed ID: 23092334
[TBL] [Abstract][Full Text] [Related]
4. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
[TBL] [Abstract][Full Text] [Related]
5. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
Wang Y; Lazo JS
Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
[TBL] [Abstract][Full Text] [Related]
6. PRL-3: a metastasis-associated phosphatase in search of a function.
Bessette DC; Wong PC; Pallen CJ
Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
[TBL] [Abstract][Full Text] [Related]
7. Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3.
Abdollahi P; Vandsemb EN; Hjort MA; Misund K; Holien T; Sponaas AM; Rø TB; Slørdahl TS; Børset M
Mol Cancer Res; 2017 Jan; 15(1):69-77. PubMed ID: 27698077
[TBL] [Abstract][Full Text] [Related]
8. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
Mizuuchi E; Semba S; Kodama Y; Yokozaki H
Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
[TBL] [Abstract][Full Text] [Related]
9. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
10. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
11. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.
Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM
Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788
[TBL] [Abstract][Full Text] [Related]
12. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 phosphatase and cancer metastasis.
Al-Aidaroos AQ; Zeng Q
J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
15. PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60.
Leung WH; Vong QP; Lin W; Bouck D; Wendt S; Sullivan E; Li Y; Bari R; Chen T; Leung W
J Immunol; 2015 Mar; 194(6):2930-41. PubMed ID: 25687758
[TBL] [Abstract][Full Text] [Related]
16. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
17. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
18. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells].
Fan Y; Zhang YL; Zheng S
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055
[TBL] [Abstract][Full Text] [Related]
19. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
